🇺🇸 FDA
Pipeline program

PYX-201

PYX-201-102

Phase 2 small_molecule active

Quick answer

PYX-201 for Advanced Solid Tumors is a Phase 2 program (small_molecule) at Pyxis Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Pyxis Oncology
Indication
Advanced Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials